Hyperliquid Strategies posts $318 million net loss on $262 million unrealized HYPE losses
Summary
Nasdaq-listed Hyperliquid Strategies Inc. reported a net loss of $317.9 million for the six months ending December 31, 2025, with total assets at $616.7 million. The primary driver of this loss was $262.4 million in unrealized losses on its HYPE token holdings, compounded by a $35.6 million IPR&D write-off related to its recent merger with Sonnet BioTherapeutics Holdings and a $17.8 million increase in deferred tax expense. Despite the loss, the company maintains a robust balance sheet with $589.8 million in stockholders' equity and no debt. CEO David Schamis expressed optimism, citing the company's alignment with Hyperliquid's growth trajectory, which features significant fee generation from its perpetuals decentralized exchange. As of early February, Hyperliquid Strategies held 17.6 million HYPE tokens and had $125 million in remaining deployable capital.
(Source:The Block)